VYNE Therapeutics Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for VYNE Therapeutics in the last 12 months.

Price Target: n/a

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for VYNE Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	1	1	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 30, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5.75 → $4.5	Strong Buy	Maintains	$5.75 → $4.5	+614.29%	Apr 25, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+812.70%	Mar 6, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+812.70%	Feb 19, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+812.70%	Jan 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

357.00K

from 570.00K

-37.37%

from 570.00K

Revenue Next Year

n/a

from 357.00K

EPS This Year

-0.93

from -0.62

EPS Next Year

-1.68

from -0.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	931.00K	477.00K	424.00K	501.00K	570.00K	357.00K	-
Revenue Growth	-95.57%	-48.77%	-11.11%	18.16%	13.77%	-37.37%	-
EPS	-25.65	-7.28	-2.78	-0.94	-0.62	-0.93	-1.68
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	735,000	n/a
Avg	357,000	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	28.9%	-
Avg	-37.4%	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.77	-1.73
Avg	-0.93	-1.68
Low	-1.08	-1.62

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.